KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Total Liabilities: 2010-2025

Historic Total Liabilities for Emergent BioSolutions (EBS) over the last 16 years, with Sep 2025 value amounting to $878.5 million.

  • Emergent BioSolutions' Total Liabilities fell 9.38% to $878.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $878.5 million, marking a year-over-year decrease of 9.38%. This contributed to the annual value of $906.9 million for FY2024, which is 22.74% down from last year.
  • Latest data reveals that Emergent BioSolutions reported Total Liabilities of $878.5 million as of Q3 2025, which was down 0.27% from $880.9 million recorded in Q2 2025.
  • Emergent BioSolutions' 5-year Total Liabilities high stood at $1.8 billion for Q4 2022, and its period low was $873.4 million during Q1 2025.
  • Its 3-year average for Total Liabilities is $1.1 billion, with a median of $1.1 billion in 2024.
  • As far as peak fluctuations go, Emergent BioSolutions' Total Liabilities surged by 44.98% in 2023, and later plummeted by 34.77% in 2024.
  • Quarterly analysis of 5 years shows Emergent BioSolutions' Total Liabilities stood at $1.3 billion in 2021, then surged by 32.12% to $1.8 billion in 2022, then tumbled by 34.00% to $1.2 billion in 2023, then decreased by 22.74% to $906.9 million in 2024, then fell by 9.38% to $878.5 million in 2025.
  • Its Total Liabilities was $878.5 million in Q3 2025, compared to $880.9 million in Q2 2025 and $873.4 million in Q1 2025.